|
Video: What is a Stock Split?
|
|
Impel Pharmaceuticals is a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases with unmet medical needs, with an initial focus on the Central Nervous System. Co. has launched Trudhesa for the acute treatment of migraine headaches with or without aura in adult patients. Co. is developing several product candidates, including INP105 for the acute treatment of agitation and aggression in patients with Autism Spectrum Disorder. Co.'s pipeline of proprietary product candidates also includes INP107 for the treatment of OFF episodes in Parkinson's Disease. According to our IMPL split history records, IMPL has had 1 split. | |
|
IMPL (IMPL) has 1 split in our IMPL split history database. The split for IMPL took place on March 23, 2005. This was a 1 for 4 reverse split, meaning for each 4 shares of IMPL owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 250 share position following the split.
When a company such as IMPL conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the IMPL split history from start to finish, an original position size of 1000 shares would have turned into 250 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into IMPL shares, starting with a $10,000 purchase of IMPL, presented on a split-history-adjusted basis factoring in the complete IMPL split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/26/2021 |
|
End date: |
12/20/2023 |
|
Start price/share: |
$15.16 |
|
End price/share: |
$0.04 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.74% |
|
Average Annual Total Return: |
-89.34% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$26.40 |
|
Years: |
2.65 |
|
|
|
Date |
Ratio |
03/23/2005 | 1 for 4 |
|
|